Can-Fite BioPharma Ltd.
Cash Flow Statement
| Line Item | FY2017 | FY2016 |
|---|---|---|
| Operating Activities | ||
| Net Income | $-6.3M | $8.3M |
| Depreciation & Amortization | — | — |
| Depreciation | $19.0K | — |
| Amortization | — | — |
| Stock-Based Compensation | — | — |
| Net Cash from Operating Activities | $-9.0M | $-8.7M |
| Investing Activities | ||
| Capital Expenditures | $7.0K | $10.0K |
| Business Acquisitions | — | — |
| Net Cash from Investing Activities | $-29.0K | $-10.0K |
| Financing Activities | ||
| Dividends Paid | — | — |
| Stock Repurchases | — | — |
| Net Cash from Financing Activities | $4.5M | — |
| Net Change in Cash | $-4.6M | $-8.8M |
| Free Cash Flow | $-9.0M | $-8.7M |